These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 9188084)
41. Differential associations of lower cardiac vagal tone with insulin resistance and insulin secretion in recently diagnosed type 1 and type 2 diabetes. Ziegler D; Strom A; Bönhof G; Püttgen S; Bódis K; Burkart V; Müssig K; Szendroedi J; Markgraf DF; Roden M; Metabolism; 2018 Feb; 79():1-9. PubMed ID: 29113812 [TBL] [Abstract][Full Text] [Related]
42. Glucagon-like peptide 1 increases secretory burst mass of pulsatile insulin secretion in patients with type 2 diabetes and impaired glucose tolerance. Ritzel R; Schulte M; Pørksen N; Nauck MS; Holst JJ; Juhl C; März W; Schmitz O; Schmiegel WH; Nauck MA Diabetes; 2001 Apr; 50(4):776-84. PubMed ID: 11289042 [TBL] [Abstract][Full Text] [Related]
43. Autonomic nervous control of the endocrine secretion from the isolated, perfused pig pancreas. Holst JJ; Schwartz TW; Knuhtsen S; Jensen SL; Nielsen OV J Auton Nerv Syst; 1986 Sep; 17(1):71-84. PubMed ID: 2877020 [TBL] [Abstract][Full Text] [Related]
44. Vagal hepatopancreatic reflex effect evoked by intraportal appearance of tGLP-1. Nakabayashi H; Nishizawa M; Nakagawa A; Takeda R; Niijima A Am J Physiol; 1996 Nov; 271(5 Pt 1):E808-13. PubMed ID: 8944665 [TBL] [Abstract][Full Text] [Related]
45. Effect of cephalic-vagal stimulation on insulin, gastric inhibitory polypeptide, and pancreatic polypeptide release in humans. Taylor IL; Feldman M J Clin Endocrinol Metab; 1982 Dec; 55(6):1114-7. PubMed ID: 6752165 [TBL] [Abstract][Full Text] [Related]
46. Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas. Gutniak MK; Juntti-Berggren L; Hellström PM; Guenifi A; Holst JJ; Efendic S Diabetes Care; 1996 Aug; 19(8):857-63. PubMed ID: 8842604 [TBL] [Abstract][Full Text] [Related]
47. Nervous control of pancreatic endocrine secretion in pigs. II. The effect of pharmacological blocking agents on the response to vagal stimulation. Holst JJ; Grønholt R; Schaffalitzky de Muckadell OB; Fahrenkrug J Acta Physiol Scand; 1981 Jan; 111(1):9-14. PubMed ID: 6111894 [TBL] [Abstract][Full Text] [Related]
48. The insulinotropic effect of exogenous glucagon-like peptide-1 is not affected by acute vagotomy in anaesthetized pigs. Veedfald S; Hansen M; Christensen LW; Larsen SA; Hjøllund KR; Plamboeck A; Hartmann B; Deacon CF; Holst JJ Exp Physiol; 2016 Jul; 101(7):895-912. PubMed ID: 27027735 [TBL] [Abstract][Full Text] [Related]
49. Insulin secretory capacity and the regulation of glucagon secretion in diabetic and non-diabetic alcoholic cirrhotic patients. Kruszynska YT; Goulas S; Wollen N; McIntyre N J Hepatol; 1998 Feb; 28(2):280-91. PubMed ID: 9514541 [TBL] [Abstract][Full Text] [Related]
50. Differential effects of ambient blood glucose level and degree of obesity on basal serum C-peptide level and the C-peptide response to glucose and glucagon in non-insulin-dependent diabetes mellitus. Park SW; Ihm SH; Yoo HJ; Park JY; Lee KU Diabetes Res Clin Pract; 1997 Sep; 37(3):165-71. PubMed ID: 9306037 [TBL] [Abstract][Full Text] [Related]
51. Effects of certain metabolites on pancreatic endocrine responses to stimulation of the vagus nerves in conscious calves. Bloom SR; Edwards AV J Physiol; 1985 May; 362():303-10. PubMed ID: 3894623 [TBL] [Abstract][Full Text] [Related]
52. The role of vagal integrity in gastrin releasing peptide stimulated gastroenteropancreatic hormone release and gastric acid secretion. Greenberg GR; Chan B; McDonald TJ; Alleyne J Regul Pept; 1985 Mar; 10(2-3):179-87. PubMed ID: 3887501 [TBL] [Abstract][Full Text] [Related]
53. Effect of atropine on insulin secretion in healthy subjects. Harju E; Nordback I J Int Med Res; 1987; 15(3):167-9. PubMed ID: 3301456 [TBL] [Abstract][Full Text] [Related]
54. Responses of hepatic and celiac vagal afferents to intraportal mercaptoacetate in rats fed a high-fat or low-fat diet. Randich A; Spraggins DS; Meller ST; Kelm GR; Cox JE Neuroreport; 2002 Apr; 13(5):675-9. PubMed ID: 11973469 [TBL] [Abstract][Full Text] [Related]
55. Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients. Willms B; Werner J; Holst JJ; Orskov C; Creutzfeldt W; Nauck MA J Clin Endocrinol Metab; 1996 Jan; 81(1):327-32. PubMed ID: 8550773 [TBL] [Abstract][Full Text] [Related]
56. Effect of galanin and vagal integrity on insulin release in dogs. Greenberg GR; McDonald TJ Pancreas; 1988; 3(2):122-7. PubMed ID: 2453871 [TBL] [Abstract][Full Text] [Related]
57. Progressive and concurrent deterioration of vagus-stimulated and hypoglycemia-induced glucagon secretion in streptozotocin-diabetic rats. Hertelendy ZI; Patel DG; Skau KA Acta Endocrinol (Copenh); 1992 Jan; 126(1):80-4. PubMed ID: 1736551 [TBL] [Abstract][Full Text] [Related]
58. The effect of truncal and selective vagotomy on the release of pancreatic glucagon, insulin and enteroglucagon. Russell RC; Thomson JP; Bloom SR Br J Surg; 1974 Oct; 61(10):821-4. PubMed ID: 4416224 [No Abstract] [Full Text] [Related]
59. Receptor-mediated activation of gastric vagal afferents by glucagon-like peptide-1 in the rat. Bucinskaite V; Tolessa T; Pedersen J; Rydqvist B; Zerihun L; Holst JJ; Hellström PM Neurogastroenterol Motil; 2009 Sep; 21(9):978-e78. PubMed ID: 19453518 [TBL] [Abstract][Full Text] [Related]